Literature DB >> 6321492

Intracellular processing of epidermal growth factor. I. Acidification of 125I-epidermal growth factor in intracellular organelles.

L M Matrisian, S R Planck, B E Magun.   

Abstract

We previously reported that 125I-labeled epidermal growth factor is processed intracellularly to acidic macromolecules in Rat-1 fibroblasts. The present study defines the precursor-product relationship and localization of the processing steps to subcellular organelles by the use of a single isoelectric species of 125I-epidermal growth factor and Percoll gradient fractionation. The native pI 4.55 125I-epidermal growth factor was rapidly processed to a pI 4.2 species on or near the cell surface and in organelles corresponding to clathrin-coated vesicles, Golgi, and endoplasmic reticulum. This species was then processed to a pI 4.35 species in similar organelles. The pI 4.2 and 4.35 species were converted to a pI 4.0 species in dense, lysosome-like organelles. This species was ultimately degraded and exocytosed from the cell as low molecular weight products.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321492

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation.

Authors:  H Sunada; B E Magun; J Mendelsohn; C L MacLeod
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 2.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

3.  Development and validation of two solid-phase enzyme immunoassays (ELISA) for quantitation of human epidermal growth factors (hEGFs).

Authors:  N Sizemore; R C Dudeck; C M Barksdale; G D Nordblom; W T Mueller; P McConnell; D S Wright; A Guglietta; B S Kuo
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

4.  Characterization of macrophage sensitivity and resistance to anthrax lethal toxin.

Authors:  A M Friedlander; R Bhatnagar; S H Leppla; L Johnson; Y Singh
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

5.  Transepithelial transport of epidermal growth factor by absorptive cells of suckling rat ileum.

Authors:  P A Gonnella; K Siminoski; R A Murphy; M R Neutra
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

6.  Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats.

Authors:  C O Juhl; L Vinter-Jensen; S S Poulsen; T F Orntoft; E Z Dajani
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

7.  Recycling of epidermal growth factor in a human pancreatic carcinoma cell line.

Authors:  M Korc; B E Magun
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Selective degradation of insulin within rat liver endosomes.

Authors:  J J Doherty; D G Kay; W H Lai; B I Posner; J J Bergeron
Journal:  J Cell Biol       Date:  1990-01       Impact factor: 10.539

9.  EGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal Therapy.

Authors:  Catarina Oliveira Silva; Steffen B Petersen; Catarina Pinto Reis; Patrícia Rijo; Jesús Molpeceres; Ana Sofia Fernandes; Odete Gonçalves; Andreia C Gomes; Isabel Correia; Henrik Vorum; Maria Teresa Neves-Petersen
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.